Information Journal Paper
APA:
Copy. (2019). lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer. MOLECULAR THERAPY - NUCLEIC ACIDS, -(-), 0-0. SID. https://sid.ir/paper/977307/en
Vancouver:
Copy. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer. MOLECULAR THERAPY - NUCLEIC ACIDS[Internet]. 2019;-(-):0-0. Available from: https://sid.ir/paper/977307/en
IEEE:
Copy, “lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer,” MOLECULAR THERAPY - NUCLEIC ACIDS, vol. -, no. -, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/977307/en